Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ENGNW

enGene Therapeutics Inc.

CIK 0001980845 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$0.32
↑ 0.00 (0.00%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BearishOverall score · based on 2/4 lenses
FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Technicals; Excluded: Ownership, Options (no data)

Key stats

Market Cap
$21.44M
P/E Ratio
-0.17
EPS
2.29
Dividend Yield
Not covered
52W Position
5%
Beta
4.00

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
0.08
P/S
Not covered
EV/Revenue
Not covered
ROE
-49.7%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 5%
$0.11$4.20

Latest Financials

2025-10-31 FY
Revenue
–
Net Income
-$117.30M
Total Assets
$221.47M
Free Cash Flow
-$100.72M

Recent news